American News Group News Commentary, Artificial intelligence has become a fixture in biotech marketing, but the more consequential question is where it is actually used: in the slide deck, or at the ...

LUND, SE / ACCESS Newswire / July 2, 2026 / Alligator Bioscience (STO:ATORX)First patient dosed in an investigator-initiated trial evaluating intratumoral mitazalimab, with or without intratumoral ...

The study shows that EGFR-TKIs induce TROP2 upregulation in DTP cells, providing a mechanistic basis for combining sac-TMT with EGFR-TKI.

Biotech Insider News Commentary -- Most clinical-stage cancer companies with three drugs that have reached human trials carry valuations in the hundreds of millions of dollars, or more. GT Biopharma, ...

Recommendation supported by unprecedented Phase 3 data, demonstrating that TECVAYLI® in combination with daratumumab achieved statistically significant improvements in progression-free and overall ...

Data readout for SIM0505/CDH6 ADC Phase 1 dose escalation study and initiation of dose optimization in ovarian cancer are both anticipated in Q2 2026 LNCB74 Phase 1 dose escalation trial update ...

CAR-T cells must overcome cancer’s many defenses in order to mount an effective attack. Lulu Perez, CC BY-SA You might think of cancer as a mass of rogue cells that grow uncontrollably. But cancer is ...

You might think of cancer as a mass of rogue cells that grow uncontrollably. But cancer is more organized and strategic than that. Rather, cancer is a tightly controlled cellular neighborhood that can ...

Recently published Non-muscle Invasive Bladder Cancer Market Insights report includes a comprehensive understanding of ...

RLTs were a hot topic at ASCO 2026, but experts note that certain limitations must be addressed to facilitate their widespread use in cancer care.

Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...